Johnson & Johnson is trading 3.6% down at $255.87 as the stock faces profit-taking after recent gains pushed shares toward record levels.
- The decline comes amid a broader sell-off in the healthcare sector sparked by concerns regarding managed care margins.
- Despite the price drop, the company's fundamentals remain supported by strong second-quarter results and recently raised full-year guidance.